ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer

Plymouth, Ml-September 3, 2014. ProNAi Therapeutics, Inc., a developer of novel nucleic acid therapeutics, announces the appointment Nick Glover, Ph.D. as President and Chief Executive Officer. The company’s previous CEO, Mina Sooch, will be leaving the organization to pursue new opportunities.

Dr. Glover, an accomplished biotech executive, brings to ProNAi Therapeutics extensive experience in the field of oncology drug development. Dr. Glover most recently served as President and Chief Executive Officer of YM Biosciences Inc. (NYSE: YMI; TSX: YM), a publicly traded oncology drug development company acquired by Gilead Sciences Inc. in February 2013.

Read more: ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer